Abstract
Neural precursors that are found in the subventricular zone and dentate gyrus of the adult brain might be useful in cell replacement therapies for neurological disorders. The development of pharmacological drugs that would increase production of new neurons would be facilitated by identification of the endogenous or natural molecular regulators of adult neurogenesis in vivo. This review discusses known endogenous regulators of the cellular events that are required for functional neurogenesis in adult animals. These steps include proliferation of stem cells and progenitors, survival and migration of new neuroblasts, differentiation into mature neurons and functional integration into existing neural circuits. Various treatments have been shown to enhance neurogenesis and neuroblast migration in adult rodents, raising the possibility that these resident neural stem cells could be used to treat people with neurological disorders. This review also highlights some of the potential problems and limitations that may arise when considering such therapies.
Keywords: Dentate gyrus, growth factor, integrin, migration, neural stem cell, neurodegenerative, subventricular, transmitter
Current Pharmaceutical Design
Title: Endogenous Regulators of Adult CNS Neurogenesis
Volume: 13 Issue: 18
Author(s): Theo Hagg
Affiliation:
Keywords: Dentate gyrus, growth factor, integrin, migration, neural stem cell, neurodegenerative, subventricular, transmitter
Abstract: Neural precursors that are found in the subventricular zone and dentate gyrus of the adult brain might be useful in cell replacement therapies for neurological disorders. The development of pharmacological drugs that would increase production of new neurons would be facilitated by identification of the endogenous or natural molecular regulators of adult neurogenesis in vivo. This review discusses known endogenous regulators of the cellular events that are required for functional neurogenesis in adult animals. These steps include proliferation of stem cells and progenitors, survival and migration of new neuroblasts, differentiation into mature neurons and functional integration into existing neural circuits. Various treatments have been shown to enhance neurogenesis and neuroblast migration in adult rodents, raising the possibility that these resident neural stem cells could be used to treat people with neurological disorders. This review also highlights some of the potential problems and limitations that may arise when considering such therapies.
Export Options
About this article
Cite this article as:
Theo Hagg , Endogenous Regulators of Adult CNS Neurogenesis, Current Pharmaceutical Design 2007; 13 (18) . https://dx.doi.org/10.2174/138161207780858393
DOI https://dx.doi.org/10.2174/138161207780858393 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Green Chemistry Starting from 2H-Pyran-2-one Derivatives
Current Green Chemistry Proteomics in the Search for Biomarkers of Animal Cancer
Current Protein & Peptide Science Characterization of Breast Lesions by Magnetic Resonance Imaging (MRI) and Spectroscopy (MRS)
Current Medical Imaging Mitochondrial and Nuclear Genes of Mitochondrial Components in Cancer
Current Genomics Antiangiogenesis and Radiotherapy: What Is the Role of Combined Modality Treatment?
Current Medicinal Chemistry - Anti-Cancer Agents Lentiviral Vectors: A Versatile Tool to Fight Cancer
Current Molecular Medicine CD95 Signaling in Cancer Treatment
Current Pharmaceutical Design Receptor-Specific Peptides for Targeting of Liposomal, Polymeric, and Dendrimeric Nanoparticles in Cancer Diagnosis and Therapy
Current Molecular Imaging (Discontinued) Targeting Death Receptors to Fight Cancer: From Biological Rational to Clinical Implementation
Current Medicinal Chemistry Prospects of miRNA-Based Therapy for Pancreatic Cancer
Current Drug Targets Design and Synthesis of Novel Thiosemicarbazones as Potent Anti-breast Cancer Agents
Letters in Drug Design & Discovery Expression and Function of Angiomodulating Cytokines in Rheumatoid Arthritis and Experimental Arthritis: Important Therapeutic Targets
Current Immunology Reviews (Discontinued) Towards Human on a Chip: Recent Progress and Future Perspective
Micro and Nanosystems Dendritic Cells in Esophageal Adenocarcinoma: The Currently Available Information and Possibilities to use Dendritic Cells for Immunotherapeutic Approaches
Current Pharmaceutical Design Editorial [Hot Topic: Herpes Simplex Virus Type 1-Based Amplicons Vectors (Guest Editor: Alberto L. Epstein)]
Current Gene Therapy Chromosome 17 in Fronto Temporal Lobak Degeneration (FTLD): From MAPT to Progranulin and Back
Current Alzheimer Research Upregulated Long Non-coding RNA ALMS1-IT1 Promotes Neuroinflammation by Activating NF-κB Signaling in Ischemic Cerebral Injury
Current Pharmaceutical Design Synthesis of Arylpiperazine Derivatives as Protease Activated Receptor 1 Antagonists and Their Evaluation as Antiproliferative Agents
Anti-Cancer Agents in Medicinal Chemistry 2-Methoxyestradiol as a Potential Cytostatic Drug in Gliomas?
Anti-Cancer Agents in Medicinal Chemistry Identification of Phosphoproteins and their Impact as Biomarkers in Cancer Therapeutics
Current Signal Transduction Therapy